Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology
|
March 11, 2014
[Incomplete self-castration by the patient with gender identify disorder: a case report]
Fumitake Kai, Daisuke Motoyama, Toshiyuki Un-no, et al.
Japanese Journal of Clinical Oncology
|
May 14, 2013
Axitinib controlled metastatic renal cell carcinoma for 5 years
Tatsuya Takayama, Masao Nagata, Fumitake Kai, et al.
Medical Oncology (Northwood, London, England)
|
April 4, 2013
Temsirolimus controlled metastatic advanced renal cell carcinoma for over 4 years: a case study
Tatsuya Takayama, Hiroshi Furuse, Fumitake Kai, et al.
Clinical and Experimental Nephrology
|
December 1, 2010
Natural history of renal cell carcinoma: a case with 18 years follow-up
Fumitake Kai, Tatsuya Takayama, Toshiki Ito, et al.
Cancer Investigation
|
April 14, 2017
Stabilization of the p53-DNA Complex by the Nuclear Protein Dmp1α
Robert D Kendig, Fumitake Kai, Elizabeth A Fry, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
September 17, 2005
[Interferon-based cytokine therapy for advanced renal cell carcinoma]
Tatsuya Takayama, Fumitake Kai, Takayuki Sugiyama, et al.
Japanese Journal of Clinical Oncology
|
April 14, 2009
Efficacy of adjuvant interferon-alpha therapy following curative resection in renal cell carcinoma: before the molecular targeting therapy era
Fumitake Kai, Tatsuya Takayama, Takayuki Sugiyama, et al.
International Journal of Molecular Sciences
|
October 30, 2020
Survival of Lung Cancer Patients Dependent on the LOH Status for <i>DMP1</i>, <i>ARF</i>, and <i>p53</i>
Elizabeth A Fry, Gloria E Niehans, Robert A Kratzke, et al.
Japanese Journal of Clinical Oncology
|
April 19, 2011
Should ipsilateral solitary adrenal involvement in renal cell carcinoma be staged as M1?
Tatsuya Takayama, Takayuki Sugiyama, Fumitake Kai, et al.
Clinical Medicine Insights. Oncology
|
June 23, 2010
Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance
Pankaj Taneja, Dejan Maglic, Fumitake Kai, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology
|
March 11, 2014
[Incomplete self-castration by the patient with gender identify disorder: a case report]
Fumitake Kai, Daisuke Motoyama, Toshiyuki Un-no, et al.
Japanese Journal of Clinical Oncology
|
May 14, 2013
Axitinib controlled metastatic renal cell carcinoma for 5 years
Tatsuya Takayama, Masao Nagata, Fumitake Kai, et al.
Medical Oncology (Northwood, London, England)
|
April 4, 2013
Temsirolimus controlled metastatic advanced renal cell carcinoma for over 4 years: a case study
Tatsuya Takayama, Hiroshi Furuse, Fumitake Kai, et al.
Clinical and Experimental Nephrology
|
December 1, 2010
Natural history of renal cell carcinoma: a case with 18 years follow-up
Fumitake Kai, Tatsuya Takayama, Toshiki Ito, et al.
Cancer Investigation
|
April 14, 2017
Stabilization of the p53-DNA Complex by the Nuclear Protein Dmp1α
Robert D Kendig, Fumitake Kai, Elizabeth A Fry, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
September 17, 2005
[Interferon-based cytokine therapy for advanced renal cell carcinoma]
Tatsuya Takayama, Fumitake Kai, Takayuki Sugiyama, et al.
Japanese Journal of Clinical Oncology
|
April 14, 2009
Efficacy of adjuvant interferon-alpha therapy following curative resection in renal cell carcinoma: before the molecular targeting therapy era
Fumitake Kai, Tatsuya Takayama, Takayuki Sugiyama, et al.
International Journal of Molecular Sciences
|
October 30, 2020
Survival of Lung Cancer Patients Dependent on the LOH Status for <i>DMP1</i>, <i>ARF</i>, and <i>p53</i>
Elizabeth A Fry, Gloria E Niehans, Robert A Kratzke, et al.
Japanese Journal of Clinical Oncology
|
April 19, 2011
Should ipsilateral solitary adrenal involvement in renal cell carcinoma be staged as M1?
Tatsuya Takayama, Takayuki Sugiyama, Fumitake Kai, et al.
Clinical Medicine Insights. Oncology
|
June 23, 2010
Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance
Pankaj Taneja, Dejan Maglic, Fumitake Kai, et al.
Page
of 2